277 related articles for article (PubMed ID: 2189135)
1. The use of recombinant human granulocyte-macrophage colony-stimulating factor in autologous bone marrow transplantation.
Peters WP; Kurtzberg J; Atwater S; Borowitz M; Rao M; Currie M; Gilbert C; Shpall EJ; Jones RB; Ross M
Prog Clin Biol Res; 1990; 338():121-8. PubMed ID: 2189135
[No Abstract] [Full Text] [Related]
2. Granulocyte-macrophage colony-stimulating factor and marrow transplantation.
Sauter C
N Engl J Med; 1988 Sep; 319(13):870-1. PubMed ID: 3045556
[No Abstract] [Full Text] [Related]
3. Effect of recombinant human granulocyte-macrophage colony-stimulating factor on hematopoietic reconstitution after high-dose chemotherapy and autologous bone marrow transplantation.
Brandt SJ; Peters WP; Atwater SK; Kurtzberg J; Borowitz MJ; Jones RB; Shpall EJ; Bast RC; Gilbert CJ; Oette DH
N Engl J Med; 1988 Apr; 318(14):869-76. PubMed ID: 3281007
[TBL] [Abstract][Full Text] [Related]
4. Effects of recombinant human granulocyte-colony stimulating factor on hematopoietic reconstitution after autologous bone marrow transplantation in primates.
Gillio AP; Bonilla MA; Potter GK; Gabrilove JL; O'Reilly RJ; Souza LM; Welte K
Transplant Proc; 1987 Dec; 19(6 Suppl 7):153-6. PubMed ID: 3321642
[No Abstract] [Full Text] [Related]
5. Recombinant granulocyte/macrophage-colony stimulating factor in human and murine bone marrow transplantation.
Blazar BR; Widmer MB; Kersey JH; Ramsay NK; McGlave PB; Urdal DL; Gillis S; Henney C; Vallera DA
Behring Inst Mitt; 1988 Aug; (83):170-80. PubMed ID: 3071335
[TBL] [Abstract][Full Text] [Related]
6. [High dose chemotherapy in malignant gliomas using autologous bone marrow transplantation and GM-CSF: granulocyte-macrophage colony stimulating factors].
Yamashita J; Kawamura T; Shoin K
No Shinkei Geka; 1990 Apr; 18(4):329-38. PubMed ID: 2197571
[No Abstract] [Full Text] [Related]
7. Recombinant human granulocyte-macrophage colony stimulating factor (rh GM-CSF) after bone marrow transplantation.
Link H; Freund M; Kirchner H; Stoll M; Schmid H; Bucsky P; Seidel J; Schulz G; Schmidt RE; Riehm H
Behring Inst Mitt; 1988 Aug; (83):313-9. PubMed ID: 3071346
[TBL] [Abstract][Full Text] [Related]
8. Hematopoietic growth factors in bone marrow transplantation for hematologic malignancies.
Lazarus HM
Prog Clin Biol Res; 1990; 352():531-8. PubMed ID: 1698303
[No Abstract] [Full Text] [Related]
9. Clinical use of GM-CSF in autologous bone marrow transplantation.
Carella AM; Gaozza E; Piatti G; Giordano D; Santini G; Carlier P; Raffo MR; Nati AS; Congin A; Bacigalupo A
Int J Cell Cloning; 1990 Jan; 8 Suppl 1():279-82. PubMed ID: 2182740
[TBL] [Abstract][Full Text] [Related]
10. Human recombinant hemopoietic growth factors G-CSF and GM-CSF: first results of clinical trials.
Nissen-Druey C
Nouv Rev Fr Hematol (1978); 1989; 31(2):99-101. PubMed ID: 2475852
[No Abstract] [Full Text] [Related]
11. GM-CSF accelerates neutrophil recovery after autologous bone marrow transplantation for Hodgkin's disease.
Devereaux S; Linch DC; Gribben JG; McMillan A; Patterson K; Goldstone AH
Bone Marrow Transplant; 1989 Jan; 4(1):49-54. PubMed ID: 2647187
[TBL] [Abstract][Full Text] [Related]
12. Clinical role of granulocyte-macrophage colony-stimulating factor.
Mitsuyasu RT; Golde DW
Hematol Oncol Clin North Am; 1989 Sep; 3(3):411-25. PubMed ID: 2698875
[TBL] [Abstract][Full Text] [Related]
13. Serum colony stimulating factors in patients undergoing bone marrow transplantation: enhancing effect of recombinant human GM-CSF.
Geissler D; Niederwieser D; Aulitzky WE; Tilg H; Grünewald K; Huber C; Konwalinka G
Behring Inst Mitt; 1988 Aug; (83):289-300. PubMed ID: 3071343
[TBL] [Abstract][Full Text] [Related]
14. The additive effect of peripheral blood stem cells, harvested with low-dose cyclophosphamide, to autologous bone marrow reinfusion on hematopoietic reconstitution after ablative chemotherapy in breast cancer patients with localized disease.
de Graaf H; Mulder NH; Willemse PH; van der Graaf WT; Sleijfer DT; Zijlstra JG; Elias M; Sibinga CT; Vellenga E; de Vries EG
Anticancer Res; 1995; 15(6B):2851-6. PubMed ID: 8669878
[TBL] [Abstract][Full Text] [Related]
15. Colony-stimulating factors in the treatment of HIV-associated non-Hodgkin's lymphoma.
Walsh C
Oncology (Williston Park); 1989 Oct; 3(10):79-83; discussion 84-6. PubMed ID: 2701212
[TBL] [Abstract][Full Text] [Related]
16. The promise of colony-stimulating factors in clinical practice.
Glaspy JA; Ambersley JM
Oncol Nurs Forum; 1990; 17(1 Suppl):20-4. PubMed ID: 1689043
[TBL] [Abstract][Full Text] [Related]
17. Recombinant human GM-CSF in myelosuppression of chemotherapy (continued).
Bar MH; Aronson FR
N Engl J Med; 1989 Apr; 320(14):939-40. PubMed ID: 2648149
[No Abstract] [Full Text] [Related]
18. Recombinant GM-CSF in myelosuppression of chemotherapy.
N Engl J Med; 1989 Jan; 320(4):253-4. PubMed ID: 2643049
[No Abstract] [Full Text] [Related]
19. Administration of human recombinant granulocyte colony-stimulating factor (filgrastim) accelerates granulocyte recovery following high-dose chemotherapy and autologous marrow transplantation with 4-hydroperoxycyclophosphamide-purged marrow in women with metastatic breast cancer.
Kennedy MJ; Davis J; Passos-Coelho J; Noga SJ; Huelskamp AM; Ohly K; Davidson NE
Cancer Res; 1993 Nov; 53(22):5424-8. PubMed ID: 7693341
[TBL] [Abstract][Full Text] [Related]
20. Hematopoietic colony-stimulating factors.
Andreeff M; Welte K
Semin Oncol; 1989 Jun; 16(3):211-29. PubMed ID: 2471272
[No Abstract] [Full Text] [Related]
[Next] [New Search]